Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Gyre Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −8 vs. Q4 2021
- Shares held
- 9.68M
- −5.37M (−35.7%) vs. Q4 2021
- Total value
- $6.39M
- −$7.36M (−53.6%) vs. Q4 2021
- New holders
- 2
- 9 more added
- Sold out
- 10
- 17 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 480 | $0 | 0.00% | +1+0.2% | Added |
| Blue Bell Private Wealth Management, LLC | 30 | $0 | 0.00% | +30 | New |
| American Portfolios Advisors | 215 | $142 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 368 | $243 | 0.00% | −96−20.7% | Reduced |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,082 | $2.00K | 0.00% | +3,033+6,189.8% | Added |
| Tower Research Capital LLC (TRC) | 3,175 | $2.00K | 0.00% | +3,175 | New |
| Cutler Group LP | 5,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 11,000 | $7.00K | 0.00% | +2,786+33.9% | Added |
| Colorado Capital Management, Inc. | 13,712 | $9.00K | 0.01% | 00.0% | Unchanged |
| Black Diamond Financial, LLC | 18,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Gyon Technologies Capital Management, LP | 23,421 | $15.0K | 0.01% | −133,129−85.0% | Reduced |
| Bank of America Corp | 24,713 | $16.0K | 0.00% | −376−1.5% | Reduced |
| Two Sigma Advisers, LP | 27,000 | $18.0K | 0.00% | −155,100−85.2% | Reduced |
| Barclays PLC | 30,102 | $20.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 32,500 | $21.0K | 0.00% | −300−0.9% | Reduced |
| HSBC Holdings PLC | 32,528 | $22.0K | 0.00% | 00.0% | Unchanged |
| Stephens Inc | 37,210 | $25.0K | 0.00% | +8,025+27.5% | Added |
| Boothbay Fund Management, LLC | 45,915 | $30.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 44,737 | $30.0K | 0.00% | +3,809+9.3% | Added |
| Morgan Stanley | 62,725 | $41.0K | 0.00% | −451,503−87.8% | Reduced |
| Two Sigma Investments, LP | 62,729 | $41.0K | 0.00% | −245,823−79.7% | Reduced |
| D. E. Shaw & Co., Inc. | 62,368 | $41.0K | 0.00% | −77,818−55.5% | Reduced |
| Johnson & Johnson | 66,951 | $44.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 72,599 | $48.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 77,127 | $51.0K | 0.00% | −415,574−84.3% | Reduced |
| Essex Woodlands Management, Inc. | 78,622 | $52.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 83,688 | $55.0K | 0.00% | −18,468−18.1% | Reduced |
| CSS LLC | 88,656 | $59.0K | 0.00% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 106,089 | $70.0K | 0.02% | −4,902−4.4% | Reduced |
| Goldman Sachs Group Inc | 117,312 | $77.0K | 0.00% | −123,299−51.2% | Reduced |
| Acadian Asset Management LLC | 118,789 | $77.0K | 0.00% | −113,611−48.9% | Reduced |
| RBF Capital, LLC | 132,396 | $87.0K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 216,807 | $143.0K | 0.00% | +141,498+187.9% | Added |
| BlackRock Inc. | 253,585 | $168.0K | 0.00% | −3,699−1.4% | Reduced |
| Geode Capital Management, LLC | 299,201 | $197.0K | 0.00% | +12,616+4.4% | Added |
| Ikarian Capital, LLC | 476,625 | $314.0K | 0.10% | +22,279+4.9% | Added |
| Millennium Management LLC | 637,799 | $421.0K | 0.00% | −271,439−29.9% | Reduced |
| Renaissance Technologies LLC | 1,169,862 | $772.0K | 0.00% | −602,046−34.0% | Reduced |
| Sabby Management, LLC | 1,320,000 | $871.0K | 0.37% | +181,666+16.0% | Added |
| Vanguard Group Inc | 1,393,512 | $920.0K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 2,420,789 | $1.60M | 0.11% | −340,871−12.3% | Reduced |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,729,402−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −512,643−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −356,804−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −67,605−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −47,441−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −31,516−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,379−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,076−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,205−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,294−100.0% | Sold out |